1887
Volume 2024, Issue 4
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Introduction: Preeclampsia and eclampsia are hypertensive disorders of pregnancy associated with significant maternal and fetal morbidity and mortality. Posterior reversible encephalopathy syndrome (PRES) is a neurological complication observed in these conditions, yet its impact on fetomaternal outcomes remains underexplored. The aim of this study is to investigate the association between PRES and fetomaternal outcomes in women with preeclampsia and eclampsia.

Methods: This prospective cohort study enrolled 64 singleton pregnant women beyond 20 weeks of gestation with preeclampsia and eclampsia having neurological symptoms. Participants underwent clinical evaluation and radiological assessment, including non-contrast computed tomography (NCCT) and magnetic resonance imaging (MRI). Maternal outcomes, including high dependency unit (HDU)/intensive care unit (ICU) stay, intubation, mode of delivery and maternal mortality. Fetal outcomes, i.e., stillbirth, prematurity, and neonatal intensive care unit (NICU) stay, were recorded. Statistical analysis was performed to compare outcomes between PRES and non-PRES groups.

Results: The majority (92.18%) of participants were unscheduled and (56.2%) were primigravida. PRES was diagnosed in 62.5% of cases, predominantly associated with antepartum eclampsia (47.5%). Neurological symptoms such as headache (85.9%) and blurring of vision (68.8%) were common in PRES cases. Cesarean section rate was significantly higher in PRES group (75%), along with adverse outcomes including increased HDU/ICU stay, intubation, postpartum haemorrhage (PPH), abruption, maternal mortality, stillbirth, prematurity, fetal growth restriction (FGR), meconium-stained liquor (MSL), and NICU stay, which were observed significantly higher in women with PRES ( < 0.001) and low Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) scores ( < 0.05). However, no significant association was observed between PRES and early neonatal death (ENND).

Conclusion: PRES is associated with adverse fetomaternal outcomes in women with preeclampsia/eclampsia, including higher cesarean section rate and increased maternal and neonatal morbidity. Early recognition and management of PRES are crucial for improving outcomes in these high-risk pregnancies. Further research with larger sample sizes is warranted to validate these findings and explore potential interventions.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.59
2024-11-11
2024-12-21
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/4/qmj.2024.59.html?itemId=/content/journals/10.5339/qmj.2024.59&mimeType=html&fmt=ahah

References

  1. Karrar SA, Hong PL. Preeclampsia. In: StatPearls. Treasure Island (FL)StatPearls Publishing;2023.
    [Google Scholar]
  2. Luger RK, Kight BP. Hypertension in pregnancy [Updated 2022 Oct 3]. In: StatPearls. Treasure Island (FL)StatPearls Publishing;2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430839/
    [Google Scholar]
  3. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020Jun; 135:(6):e237–60. https://doi.org/10.1097/AOG.0000000000003891
    [Google Scholar]
  4. Shaikh N, Nawaz S, Ummunisa F, Shahzad A, Hussain J, Ahmad K, et al.. Eclampsia and posterior reversible encephalopathy syndrome (PRES): A retrospective review of risk factors and outcomes. Qatar Med J. 2021Feb16; 2021:(1):4. https://doi.org/10.5339/qmj.2021.4
    [Google Scholar]
  5. Garg RK, Kumar N, Malhotra HS. Posterior reversible encephalopathy syndrome in eclampsia. Neurol India. 2018; 66:1316–23. https://doi.org/10.4103/0028-3886.241364
    [Google Scholar]
  6. Zou L-P, Liu L-Y, Li H, Wang Y-Y, Liu Y, Chen J, et al.. Establishment and utility assessment of posterior reversible encephalopathy syndrome early warning scoring (PEWS) scale establishment and utility assessment of PEWS scale. BMC Neurol. 2019; 19:30. https://doi.org/10.1186/s12883-019-1247-0
    [Google Scholar]
  7. Chao AS., Chen YL., Chang YL, Chao A, Su S-Y, Wang T-H. Severe pre-eclamptic women with headache: Is posterior reversible encephalopathy syndrome an associated concurrent finding? BMC Pregnancy Childbirth. 2020; 20:336. https://doi.org/10.1186/s12884-020-03017-4
    [Google Scholar]
  8. Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): Diagnosis and management. Pract Neurol. 2022; 22:183–9. https://doi.org/10.1136/practneurol-2021-003194
    [Google Scholar]
  9. Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features. Am J Neuroradiol. 2008; 29:(6):1036–42. https://doi.org/10.3174/ajnr.A0928
    [Google Scholar]
  10. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017; 264:1608–16. https://doi.org/10.1007/s00415-016-8377-8
    [Google Scholar]
  11. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: Clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015; 14:914–25. https://doi.org/10.1016/S1474-4422(15)00111-8
    [Google Scholar]
  12. Sudulagunta SR, Sodalagunta MB, Kumbhat M, Nataraju AS. Posterior reversible encephalopathy syndrome (PRES). Oxf Med Case Rep. 2017; 2017:omx011. https://doi.org/10.1093/omcr/omx011
    [Google Scholar]
  13. Hammer ES, Cipolla MJ. Cerebrovascular dysfunction in preeclamptic pregnancies. Curr Hypertens Rep. 2015; 17:64. https://doi.org/10.1007/s11906-015-0575-8
    [Google Scholar]
  14. Kurdoglu Z, Cetin O, Sayin R, Dirik D, Kurdoglu M, Kolusari A, et al.. Clinical and perinatal outcomes in eclamptic women with posterior reversible encephalopathy syndrome. Arch Gynecol Obstet. 2015; 292:(5):1013–8. https://doi.org/10.1007/s00404-015-3738-6
    [Google Scholar]
  15. Bahadur A, Mundhra R, Singh R, Mishra J, Suresh G, Jaiswal S, et al.. Predictors of posterior reversible encephalopathy syndrome (PRES) in women with pre-eclampsia/eclampsia: A retrospective analysis. Cureus. 2022; 14:(11):e31459. https://doi.org/10.7759/cureus.31459
    [Google Scholar]
  16. Bembalgi S, Kamate V, Shruthi KR. A study of eclampsia cases associated with posterior reversible encephalopathy syndrome. J Clin Diagn Res. 2015Jul; 9:(7):QC05–7. https://doi.org/10.7860/JCDR/2015/14039.6276
    [Google Scholar]
  17. Fang X, Liang Y, Chen D, He F, Chen J, Huang F. A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia. Hypertens Res. 2017; 40:(12):982–7. https://doi.org/10.1038/hr.2017.76
    [Google Scholar]
  18. Chao A-S, Chen Y-L, Chang Y-L, Chao A, Su S-Y, Wang T-H. Severe pre-eclamptic women with headache: Is posterior reversible encephalopathy syndrome an associated concurrent finding? BMC Pregnancy Childbirth. 2020; 20:(1):336. https://doi.org/10.1186/s12884-020-03017-4
    [Google Scholar]
  19. Basavarajappa H, Saha D, Bagga PK, Khandelwal R, Modi N. Neuroradiological perspectives of severe preeclampsia and eclampsia spectrum—Correlation from posterior reversible encephalopathy syndrome. Pregnancy Hypertens. 2020; 20:119–23. https://doi.org/10.1016/j.preghy.2020.04.003
    [Google Scholar]
  20. Junewar V, Verma R, Sankhwar PL, Garg RK, Singh MK, Malhotra HS, et al.. Neuroimaging features and predictors of outcome in eclamptic encephalopathy: A prospective observational study. AJNR Am J Neuroradiol. 2014; 35:(9):1728–34. https://doi.org/10.3174/ajnr.A3923
    [Google Scholar]
  21. Brewer J, Owens MY, Wallace K, Reeves AA, Morris R, Khan M, et al.. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol. 2013; 208:(6):468.e1–6. https://doi.org/10.1016/j.ajog.2013.02.015
    [Google Scholar]
  22. Hinduja A. Posterior reversible encephalopathy syndrome: Clinical features and outcome. Front Neurol. 2020; 11:71. https://doi.org/10.3389/fneur.2020.00071
    [Google Scholar]
  23. Liman TG, Bohner G, Heuschmann PU, Scheel M, Endres M, Siebert E. Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases: PRES in preeclampsia/eclampsia. Eur J Neurol. 2012; 19:(7):935–43. https://doi.org/10.1111/j.1468-1331.2011.03629.x
    [Google Scholar]
  24. Verma AK, Garg RK, Pradeep Y, Malhotra HS, Rizvi I, Kumar N, et al.. Posterior encephalopathy syndrome in women with eclampsia: Predictors and outcome. Pregnancy Hypertens. 2017; 10:74–82. https://doi.org/10.1016/j.preghy.2017.06.004
    [Google Scholar]
  25. Xiaobo F, Yanling L, Dunjin C, Fang H, Jia C, Yuhua Z, et al.. Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia. Hypertens Res. 2018; 41:(2):112–7. https://doi.org/10.1038/hr.2017.95
    [Google Scholar]
  26. Wen Y, Yang B, Huang Q, Liu Y. Posterior reversible encephalopathy syndrome in pregnancy: A retrospective series of 36 patients from mainland China. Ir J Med Sci. 2017; 186:(3):699–705. https://doi.org/10.1007/s11845-017-1567-2
    [Google Scholar]
  27. Dong XY, Bai CB, Nao JF. Clinical and radiological features of posterior reversible encephalopathy syndrome in patients with pre-eclampsia and eclampsia. Clin Radiol. 2017; 72:(10):887–95. https://doi.org/10.1016/j.crad.2017.06.009
    [Google Scholar]
  28. Thombarapu U, Dwarampudi AD, Kodey PD. Posterior reversible encephalopathy syndrome in preeclampsia. Int J Reprod Contracept Obstet Gynecol. 2020; 9:(1):358–63. https://doi.org/10.18203/2320-1770.ijrcog20196048
    [Google Scholar]
  29. Mayama M, Uno K, Tano S, Yoshihara M, Ukai M, Kishigami Y. Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms. Am J Obstet Gynecol. 2016; 215:(2):e239–40. https://doi.org/10.1016/j.ajog.2016.02.039
    [Google Scholar]
  30. Tawati DA, Chan W-S. A systematic review of posterior reversible encephalopathy syndrome in pregnant women with severe preeclampsia and eclampsia. Obstet Med. 2023; 16:(4):236–41. https://doi.org/10.1177/1753495X221150302
    [Google Scholar]
/content/journals/10.5339/qmj.2024.59
Loading
/content/journals/10.5339/qmj.2024.59
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error